As part of the contract for the issue of 10,000 issue warrants (the “Issue Warrants”) of bonds convertible into new shares to be issued by the Company (the “OCA”) with share subscription warrants attached on if applicable (the “BSA” and, together with the OCA, the “OCABSA”) entered into between Europlasma SA and Global Corporate Finance Opportunities 11 on April 16, 2021 (the “Issue Agreement”), the Company announces that it has proceeded today to draw two tranches of 100 OCA each, for a total nominal amount of € 2 million.
The Company specifies that this drawdown was carried out at the request of Global Corporate Finance Opportunities 11 in accordance with the Issue Agreement. As such, it is recalled that during the first twelve (12) months of this financing program, Global Corporate Finance has the possibility of requesting the issue of OCABSA tranches for a maximum total nominal amount of the bond loan. of 12,000,000 euros (“Investor Call”). To date, the OCABSA tranches issued within the framework of an Investor Call represent a total bond loan amount of 6,000,000 euros.